CCR5 and neoplasm: A study by Wang et al. has demonstrated that CCR2 and CCR5 are associated with TAMs infiltration in the tumor; however, targeting CCR2 or CCR5 alone does not sensitize PDAC tumors to immunosuppression in the absence of T-cell initiation mechanisms112.